Catalyst Pharmaceuticals (CPRX) Work In Process (2023 - 2025)
Historic Work In Process for Catalyst Pharmaceuticals (CPRX) over the last 3 years, with Q3 2025 value amounting to $4.6 million.
- Catalyst Pharmaceuticals' Work In Process rose 2017.77% to $4.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.6 million, marking a year-over-year increase of 2017.77%. This contributed to the annual value of $3.4 million for FY2024, which is 2466.65% down from last year.
- Latest data reveals that Catalyst Pharmaceuticals reported Work In Process of $4.6 million as of Q3 2025, which was up 2017.77% from $5.3 million recorded in Q2 2025.
- In the past 5 years, Catalyst Pharmaceuticals' Work In Process ranged from a high of $5.3 million in Q2 2025 and a low of $3.4 million during Q4 2024
- Its 3-year average for Work In Process is $4.3 million, with a median of $4.2 million in 2025.
- As far as peak fluctuations go, Catalyst Pharmaceuticals' Work In Process tumbled by 2466.65% in 2024, and later soared by 3289.41% in 2025.
- Quarter analysis of 3 years shows Catalyst Pharmaceuticals' Work In Process stood at $4.6 million in 2023, then dropped by 24.67% to $3.4 million in 2024, then skyrocketed by 33.47% to $4.6 million in 2025.
- Its Work In Process stands at $4.6 million for Q3 2025, versus $5.3 million for Q2 2025 and $4.2 million for Q1 2025.